A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 ...

Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...

Meghan Trainor revealed her transformation journey involves a mix of lifestyle changes, working with a dietitian, and using ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

The GLP-1 Support from Whole Health Rx is designed to address common dietary gaps and side effects associated with the ...

US drug developer Palatin Technologies (NYSE American: PTN) announced that its BMT-801 Phase II obesity co-administration ...

Patients without diabetes using GLP-1RAs are less likely to develop glaucoma compared with those who use other weight loss therapies.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...

Meghan Trainor has given the type 2 diabetes drug Mounjaro a special shout out when addressing her recent weight loss ...

Eli Lilly ( NYSE: LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...